SCHEMBL33378018

SCHEMBL33378018

Clc1cc(Nc2ccccn2)n2ncc(C3CC3)c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.45
▸ CDK2 P24941 6/20 0.37
▸ MAPKAPK2 P49137 2/20 0.37
▸ CSNK2A2 P19784 1/20 0.37
▸ GSK3B P49841 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPK10 P53779 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CCND3 P30281 3/20 0.35
▸ CCNA2 P20248 3/20 0.35
▸ CDK4 P11802 2/20 0.35
▸ CCND1 P24385 2/20 0.35
▸ CCND2 P30279 2/20 0.35
▸ CCNA1 P78396 2/20 0.35
▸ KDR P35968 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ GRM5 P41594 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33378033 0.85 CYP17A1 (0.36) CHEK1CDK2MAPKAPK2GSK3BCCNA2
SCHEMBL33378006 0.85 CDK2 (0.36) CHEK1CDK2MAPKAPK2CSNK2A2GSK3B
SCHEMBL33377902 0.85 CDK2 (0.35) CHEK1CDK2MAPKAPK2CSNK2A2GSK3B
SCHEMBL33378038 0.83 CHEK1 (0.43) CHEK1CDK2CSNK2A2GSK3BCCNA2
SCHEMBL33378044 0.81 GRM5 (0.39) CDK2CSNK2A2GSK3BKDRGRM5
SCHEMBL33377947 0.80 KDM4E (0.42) GSK3BKMT2A
SCHEMBL33377992 0.80 CDK2 (0.36) CDK2MAPKAPK2CSNK2A2GSK3BTYK2
SCHEMBL33377998 0.80 GSK3B (0.40) CDK2MAPKAPK2GSK3B
SCHEMBL22413270 0.78 CDK2 (0.41) CDK2MAPKAPK2GSK3BMEN1KMT2A
SCHEMBL19742549 0.78 CDK2 (0.57) CDK2MAPKAPK2CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717312-A1 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-01 — — EP disclosed
Send feedback